3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
8
Lung Neoplasms
5
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Hot Flashes
2
Glioblastoma
2
Carcinoma, Non-Small-Cell Lung
2
COVID-19
2
Brain Neoplasms
2
Water-Electrolyte Imbalance
1
Ventilator-Induced Lung Injury
1
Surgical Wound
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Severe Acute Respiratory Syndrome
1
Rectal Neoplasms
1
Postoperative Complications
1
Pathologic Complete Response
1
Neoplasm, Residual
1
Mastocytosis
1
Lymphopenia
1
Lymphoma, Non-Hodgkin
1
Lymphedema
1
Lower Urinary Tract Symptoms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Hairy Cell
1
Hypersensitivity
1
Interventions
Water
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Serum Albumin, Human
1
Saline Solution
1
Neomycin
1
Metronidazole
1
Esophagectomy
1
Ciprofloxacin
1
Bioseal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anastomotic Leak
×
Sodium Chloride
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn